With frustration growing among Americans who are being charged exorbitant prices for medical treatment, a bipartisan group of senators Tuesday unveiled a plan to protect patients from surprise bills and high charges from hospitals or doctors who are not in their insurance networks. The draft legislation, which sponsors said is designed to prevent medical bankruptcies, […]Continue Reading ...
International collaborative research led by Ludwine Messiaen, Ph.D., shows that while a three-base pair, in-frame deletion called p.Met992del in the NF1 gene has a mild phenotype for people with the genetic disorder neurofibromatosis type 1, or NF1, the mutation does cause complications. These include non-optic brain tumors, mostly low-grade and asymptomatic, as well as cognitive […]Continue Reading ...
Sep 19 2018 Patients Often Unaware That They Are Overweight or Obese A new guideline focused on the role of weight management in treating adult obstructive sleep apnea (OSA) has been published online by the American Thoracic Society in the Sept. 15 American Journal of Respiratory and Critical Care Medicine. OSA is a common disease […]Continue Reading ...
It’s hard to wrap your brain around. It’s hard to even type these words, but here they are: it’s useful for physicians to be able to predict when a patient will die. Don’t misunderstand. It’s not about playing God or acting nefarious. It’s about doctors being able to help patients die on their own terms, […]Continue Reading ...
First results from a clinical trial of a procedure to open obstructed airways in patients with chronic obstructive pulmonary disease (COPD) have shown that it significantly reduces problems associated with the disease and is safe. Presenting findings from the AIRFLOW 2 phase II clinical trial, the principal investigator, Dr Dirk-Jan Slebos, from the University Medical […]Continue Reading ...
As one of the most common malignant tumors, gastric cancer (GC) occupies the second leading cause of cancer-related deaths worldwide with an increasing trend. The reduced physiological function and low immunity in elderly patients with gastric cancer leads to a significantly increased incidence of postoperative complications. In addition, postoperative complications among elderly patients are usually […]Continue Reading ...
In a new analysis of data submitted to Maryland’s state trauma registry from 2005 to 2017, Johns Hopkins Medicine researchers found that gunshot victims are approximately five times more likely to require blood transfusions, they require 10 times more blood units and are 14 times more likely to die than people seriously injured by motor […]Continue Reading ...
Two variants of an autoimmune disease that affects thousands but is hard to diagnose are relatively common among black Africans, research shows. The findings, relating to systemic lupus erythematosus, or SLE, could improve diagnosis and treatment of the condition. They could enable better management of the disease in patients of African descent, particularly in southern […]Continue Reading ...
NORTH CHICAGO, Ill., Sept. 13, 2018 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced new patient-reported outcomes data from three pivotal Phase 3 trials evaluating risankizumab, an investigational interleukin-23 (IL-23) inhibitor, in adult patients with moderate to severe plaque psoriasis. Across all three trials, patients reported significant improvements in health-related quality […]Continue Reading ...
NEWTON, Mass., Sept. 13, 2018 (GLOBE NEWSWIRE) — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that updated clinical data from the Phase 2b STORM (Selinexor Treatment of Refractory Myeloma) study evaluating selinexor, the Company’s lead, oral Selective Inhibitor of Nuclear Export (SINE) compound, in heavily pretreated patients with penta-refractory multiple myeloma, were […]Continue Reading ...
PRINCETON, N.J.–(BUSINESS WIRE)– September 12, 2018 — Bristol-Myers Squibb Company (NYSE:BMY) today announced results from a Phase 2 study of BMS-986165, an investigational oral, selective tyrosine kinase 2 (TYK2) inhibitor, in patients with moderate to severe plaque psoriasis. Efficacy endpoints including ≥75% and 90% reduction in the Psoriasis Area and Severity Index (PASI 75, PASI […]Continue Reading ...
FRIDAY, Sept. 14, 2018 — For patients undergoing rhinoplasty, postoperative opioid refills are extremely rare, according to a research letter published online Sept. 6 in JAMA Facial Plastic Surgery. Rosh K.V. Sethi, M.D., M.P.H., from Harvard Medical School in Boston, and colleagues conducted a retrospective review of 173 patients who underwent rhinoplasty to examine opioid […]Continue Reading ...
Boehringer Ingelheim announced results from the OTIVACTO study, an observational European real-world study of 7,443 Chronic Obstructive Pulmonary Disease (COPD) patients treated with Spiolto® (tiotropium/olodaterol) Respimat®, which were presented today at the European Respiratory Society (ERS) International Congress 2018 in Paris, France. Patients in the study reported both improved physical functioning and general condition and […]Continue Reading ...
Results from INPULSIS®-ON, published today in Lancet Respiratory Medicine, provide insights into the long-term safety, efficacy and tolerability of Ofev® (nintedanib) in patients with idiopathic pulmonary fibrosis (IPF). These data suggest that the effect of nintedanib on slowing disease progression of IPF persists beyond four years.1 Results also indicate that the long-term efficacy of nintedanib […]Continue Reading ...
Patients with severe traumatic brain injury treated at Helsinki University Hospital, Finland, recover to functional independence more often than before. At the same time, the proportions of elderly patients and patients treated conservatively have increased. The study found no specific reason to explain the observed improvement in outcomes; the results are accounted for by improvements […]Continue Reading ...
- Senators unveil legislation to protect patients against surprise medical bills
- Study provides insights into development of special-purpose cosmetic products
- Research shows enlarged genotype-phenotype correlation for three-base pair deletion in NF1
- Mediterranean-style diet appears to reduce stroke risk in women
- AbbVie Announces Patient-Reported Outcomes Data from Three Pivotal Phase 3 Studies of Risankizumab, Showing Significant Improvements in Health-Related Quality of Life for Patients with Psoriasis
- Characterization of pregnancy microbiome reveals variations in bacterial diversity
- New guidance for treatment of bone loss in hematologic stem cell transplant Recipients
- Experts to present research on prevention, management of dysphagia at international conference
- New study focuses on two-way gene switches controlling gene activity
- Zika virus could become a weapon against brain cancer
- Home-based video game exercises can reduce chronic low back pain in older people, study finds
- Investigators find that bile acids reduce cocaine reward
- Cannabinoid drugs reduce perceived unpleasantness of painful stimuli and increase tolerance
- Health care companies’ data could enable more accurate flu season forecasts
- Geroscience takes center stage in Journal of the American Medical Association
- Ambient Particulate Matter Linked to Emergency Asthma Care
- Patient satisfaction with plastic surgery—it’s the surgeon, not the practice
- Medicine is a team sport – and that’s exactly how it should be
- Logos Biosystems releases new electrophoretic tissue clearing system with twice the features in half the space
- Novel micro-platform reveals never-before-seen behaviors of cancer cells